The Society for Immunotherapy of Cancer (SITC) hosted the 2021 SITC Cancer Immunotherapy Winter School, a comprehensive cancer immunotherapy education program, virtually on February 22-24, 2021. Available here are the presentation slides and video from Wednesday, February 24, 2021. Program...
24 attachments
The Society for Immunotherapy of Cancer (SITC) hosted the 2021 SITC Cancer Immunotherapy Winter School, a comprehensive cancer immunotherapy education program, virtually on February 22-24, 2021. Available here are the presentation slides and video from Tuesday, February 23, 2021. Program...
The Society for Immunotherapy of Cancer (SITC) hosted the 2021 SITC Cancer Immunotherapy Winter School, a comprehensive cancer immunotherapy education program, virtually on February 22-24, 2021. Available here are the presentation slides and video from Monday, February 22, 2021. Program...
22 attachments
FOR IMMEDIATE RELEASE Dec. 23, 2020 MILWAUKEE – The Society for Immunotherapy of Cancer (SITC) commends the global biomedical community for coming together to develop and authorize safe and effective SARS-CoV-2 vaccines at unprecedented speeds. SITC stands with the world in hoping that rapid...
The Society for Immunotherapy of Cancer’s (SITC) 36 th Annual Meeting & Pre-Conference Programs (SITC 2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. Registration and other details will be announced soon! Thank You to Our...
11-10-2021 08:00 - 11-14-2021 12:00 ET Washington DC
header image SITC Cancer Immunotherapy Guidelines Expert Panels are comprised of leaders in the immuno-oncology field who provide interdisciplinary perspectives including medical oncology, community oncology, radiation oncology, surgery, pathology, and nursing as well as other specializations,...
header image The coronavirus (COVID-19) pandemic has affected all aspects of healthcare and the oncology and immuno-oncology communities may face unique challenges in regards to patient care. As immuno-oncology practitioners treat patients during the pandemic, it has also become apparent that...
header image February 2020 JITC Reading List February 2020 The following articles have been recommended for further reading in the field of cancer immunotherapy by JITC’s Clinical/Translational Cancer Immunotherapy Section Co-Editor, James L. Gulley, MD, PhD, FACP. Safety and feasibility of...
January 2020 JITC Reading List January 2020 The following articles have been recommended for further reading in the field of cancer immunotherapy by JITC’s Commentary/editorials Section Editor, Christian Capitini, MD. “Trans-endocytosis of intact IL-15Ralpha–IL-15 complex from presenting...
Inside this Issue: Letter from the Editor JITC Editor Picks Other Recent JITC ARTICLES Letter from the Editor Dear JITC Readers, Welcome to the first JITC Digest of 2020! The past decade has seen cancer immunotherapy advance to an incredible degree, and the pace of innovation is not...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us